PHARMACIE GANSER: what changed
What changed
PHARMACIE GANSER
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Net result for the year
€43,874
2024 · €95,281-€51,407
Equity
€316,557
2024 · €474,903-€158,347
Cash
€110,430
2024 · €224,121-€113,691
Balance sheet total
€616,588
2024 · €862,369-€245,781
Largest movements
Assets
- Cash -€113,691
down €113,691 (-50.7%), from €224,121 to €110,430
mainly Contributions, distributions and other (-€202,220) and Debts after one year (-€50,763)
- Stocks and contracts -€55,959
down €55,959 (-29.9%), from €187,309 to €131,349
- Tangible fixed assets -€52,888
down €52,888 (-20.5%), from €257,575 to €204,687
- Receivables within one year -€21,767
down €21,767 (-12.4%), from €176,229 to €154,462
of which Trade receivables: -€41,773
Equity and liabilities
- Reserves -€158,347
down €158,347 (-35.2%), from €449,903 to €291,557
of which Distributable reserves: -€158,347
- Debts after one year -€50,763
down €50,763 (-42.4%), from €119,611 to €68,848
- Trade debts -€18,018
down €18,018 (-10.5%), from €171,134 to €153,116
Income statement
- Gross operating margin -€72,676
down €72,676 (-16.6%), from €439,083 to €366,407
- Taxes -€11,106
down €11,106 (-38.6%), from €28,748 to €17,641
- Staff costs -€7,768
down €7,768 (-3.3%), from €237,459 to €229,691
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€95,281
Gross operating margin
-€72,676
Staff costs
+€7,768
Depreciation
-€465
Write-downs
+€139
Other operating charges
+€614
Financial income
-€50
Financial charges
+€2,157
Taxes
+€11,106
Result 2025
€43,874
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€154,693
Investment
-€10,863
Financing
-€257,521
Cash 2024
€224,121
From operations (derived)
+€154,693
Net result for the year
+€43,874
Depreciation
+€63,751
Stocks and contracts
+€55,959
Receivables within one year
+€21,767
Deferred charges and accrued income
+€1,475
Trade debts
-€18,018
Tax, wage and social debts
-€6,541
Other debts
-€7,598
Accrued charges and deferred income
+€24
Investment (derived)
-€10,863
Investment in fixed assets (net)
-€10,863
Financing
-€257,521
Debts after one year
-€50,763
Current portion of long-term debt
-€4,538
Contributions, distributions and other
-€202,220
Cash 2025
€110,430
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €862,369 | €616,588 | -€245,781 | -28.5% |
| Fixed assets | 21/28 | €258,379 | €205,490 | -€52,888 | -20.5% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €257,575 | €204,687 | -€52,888 | -20.5% |
| Plant, machinery and equipment | 23 | €110,527 | €90,981 | -€19,546 | -17.7% |
| Furniture and vehicles | 24 | €27,579 | €12,285 | -€15,294 | -55.5% |
| Other tangible fixed assets | 26 | €119,469 | €101,420 | -€18,049 | -15.1% |
| Financial fixed assets | 28 | €803 | €803 | = | 0.0% |
| Current assets | 29/58 | €603,990 | €411,098 | -€192,893 | -31.9% |
| Stocks and contracts in progress | 3 | €187,309 | €131,349 | -€55,959 | -29.9% |
| Stocks | 30/36 | €187,309 | €131,349 | -€55,959 | -29.9% |
| Amounts receivable within one year | 40/41 | €176,229 | €154,462 | -€21,767 | -12.4% |
| Trade receivables | 40 | €163,976 | €122,203 | -€41,773 | -25.5% |
| Other amounts receivable | 41 | €12,252 | €32,259 | +€20,006 | +163% |
| Cash at bank and in hand | 54/58 | €224,121 | €110,430 | -€113,691 | -50.7% |
| Deferred charges and accrued income | 490/1 | €16,332 | €14,857 | -€1,475 | -9.0% |
| Total equity and liabilities | 10/49 | €862,369 | €616,588 | -€245,781 | -28.5% |
| Equity | 10/15 | €474,903 | €316,557 | -€158,347 | -33.3% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €449,903 | €291,557 | -€158,347 | -35.2% |
| Tax-exempt reserves | 132 | €323 | €323 | = | 0.0% |
| Distributable reserves | 133 | €449,580 | €291,233 | -€158,347 | -35.2% |
| Amounts payable | 17/49 | €387,466 | €300,031 | -€87,435 | -22.6% |
| Amounts payable after more than one year | 17 | €119,611 | €68,848 | -€50,763 | -42.4% |
| Financial debts | 170/4 | €119,611 | €68,848 | -€50,763 | -42.4% |
| Amounts payable within one year | 42/48 | €267,855 | €231,160 | -€36,695 | -13.7% |
| Current portion of amounts payable after more than one year | 42 | €55,301 | €50,763 | -€4,538 | -8.2% |
| Financial debts | 43 | €0 | €0 | = | |
| Credit institutions | 430/8 | €0 | €0 | = | |
| Trade debts | 44 | €171,134 | €153,116 | -€18,018 | -10.5% |
| Suppliers | 440/4 | €171,134 | €153,116 | -€18,018 | -10.5% |
| Taxes, remuneration and social security | 45 | €33,822 | €27,281 | -€6,541 | -19.3% |
| Taxes | 450/3 | €4,032 | €2,803 | -€1,229 | -30.5% |
| Remuneration and social security | 454/9 | €29,791 | €24,479 | -€5,312 | -17.8% |
| Other amounts payable | 47/48 | €7,598 | €0 | -€7,598 | -100% |
| Accrued charges and deferred income | 492/3 | - | €24 | +€24 | |
| Remuneration, social security and pensions | 62 | €237,459 | €229,691 | -€7,768 | -3.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €63,287 | €63,751 | +€465 | +0.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €139 | - | -€139 | |
| Other operating charges | 640/8 | €1,645 | €1,032 | -€614 | -37.3% |
| Gross operating margin | 9900 | €439,083 | €366,407 | -€72,676 | -16.6% |
| Operating profit (loss) | 9901 | €136,554 | €71,933 | -€64,620 | -47.3% |
| Financial income | 75/76B | €110 | €60 | -€50 | -45.3% |
| Recurring financial income | 75 | €110 | €60 | -€50 | -45.3% |
| Financial charges | 65/66B | €12,636 | €10,478 | -€2,157 | -17.1% |
| Recurring financial charges | 65 | €12,636 | €10,478 | -€2,157 | -17.1% |
| Profit (loss) for the period before taxes | 9903 | €124,028 | €61,515 | -€62,513 | -50.4% |
| Income taxes | 67/77 | €28,748 | €17,641 | -€11,106 | -38.6% |
| Profit (loss) for the period | 9904 | €95,281 | €43,874 | -€51,407 | -54.0% |
| Profit (loss) for the period to be appropriated | 9905 | €95,281 | €43,874 | -€51,407 | -54.0% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.